Director:Souhel Najjar, MD
Lenox Hill Hospital
Staten Island University Hospital
Chair and Professor of Neurology
Hofstra North Shore-LIJ School of Medicine
Director Emeritus: Jerome Block, MD
The Hospital's neurology section provides the diagnosis and management of disorders of the nervous system such as Epilepsy, Parkinson's disease, Stroke, brain aneurysms, brain AVMs, Multiple Sclerosis, disorders of spine and spinal cord and the treatable causes of coordination problems and dementia in the aging patient. The division of Neurology has general neurologists and offers several specialty centers: Epilepsy Center, Center for Stroke and Neuro-Endovascular Surgery, Cerebrospinal Fluid Dynamics Center, as well as a range of Neurodiagnotic tests available.
Aviva Lubin, MD Associate Director of Stroke Service: Dr. Lubin is a board certified neurologist specializing in advanced care for the complex stroke patient. She graduated from Mount Sinai School of Medicine and completed her Residency and Chief Residency at North Shore and Long Island Jewish Hospital. She then pursued a Vascular Neurology / Stroke Fellowship at Mount Sinai Hospital. Dr. Lubin has joined Lenox Hill Hospital as Associate Director of the Stroke Service. Her full time presence at the hospital assures a rapid and effective response to the needs of the growing number of stroke patients being seen at Lenox Hill Hospital. She is also available for outpatient consultations, particularly for management of patients with stroke related problems. Dr. Lubin, who is also an actuary, plans to apply her years of experience as an actuarial consultant and manager to the ongoing process of expansion and growth of stroke treatment at Lenox Hill Hospital.
Lenox Hill Hospital has received the Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American Stroke Association for the treatment of stroke patients. Lenox Hill Hospital has also received the association's Target: Stroke Honor Roll for meeting stroke quality measures that reduce the time between hospital arrival and treatment with the clot-buster tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. People who suffer a stroke who receive the drug within three hours of the onset of symptoms may recover quicker and are less likely to suffer severe disability. With this award, our hospital demonstrates our commitment to ensure that our patients receive care based on internationally-respected clinical guidelines. read more